DE3672515D1 - In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung. - Google Patents

In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.

Info

Publication number
DE3672515D1
DE3672515D1 DE8686470004T DE3672515T DE3672515D1 DE 3672515 D1 DE3672515 D1 DE 3672515D1 DE 8686470004 T DE8686470004 T DE 8686470004T DE 3672515 T DE3672515 T DE 3672515T DE 3672515 D1 DE3672515 D1 DE 3672515D1
Authority
DE
Germany
Prior art keywords
therapeutic composition
imidazolidinylurea
dermatology
basic component
composition applicable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686470004T
Other languages
English (en)
Inventor
Bensimon Claudine Andermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANBEN STRASSBURG/STRASBOURG FR
Original Assignee
ANBEN STRASSBURG/STRASBOURG FR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9317667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3672515(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ANBEN STRASSBURG/STRASBOURG FR filed Critical ANBEN STRASSBURG/STRASBOURG FR
Application granted granted Critical
Publication of DE3672515D1 publication Critical patent/DE3672515D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DE8686470004T 1985-03-26 1986-03-24 In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung. Expired - Fee Related DE3672515D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8504616A FR2579463B1 (fr) 1985-03-26 1985-03-26 Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne

Publications (1)

Publication Number Publication Date
DE3672515D1 true DE3672515D1 (de) 1990-08-16

Family

ID=9317667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686470004T Expired - Fee Related DE3672515D1 (de) 1985-03-26 1986-03-24 In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.

Country Status (5)

Country Link
EP (1) EP0197876B1 (de)
AT (1) ATE54413T1 (de)
DE (1) DE3672515D1 (de)
FR (1) FR2579463B1 (de)
IL (1) IL78269A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635682A1 (fr) * 1988-08-29 1990-03-02 Anben Composition cosmetique d'application cutanee pour reduire la sensation de brulure au rasage ou a l'epilation
US5697485A (en) 1995-12-19 1997-12-16 Otis Elevator Company Passenger conveyor control system having decentralized inputs and outputs
WO2001000158A1 (en) * 1999-06-28 2001-01-04 The Procter & Gamble Company Cosmetic compositions containing quaternary ammonium compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108840A (en) * 1981-11-04 1983-05-25 Wigglesworth Ltd Therapeutic use of imidazolidinyl urea
GB2108844A (en) * 1981-11-04 1983-05-25 Wigglesworth Ltd Therapeutic use of allantoin-formaldehyde condensation products
CA1231046A (en) * 1982-08-06 1988-01-05 William E. Rosen Composition of matter containing imidazolidinyl urea and parabens
EP0143109A1 (de) * 1983-11-23 1985-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Gelierte Salbe mit Pranoprofen

Also Published As

Publication number Publication date
FR2579463A1 (fr) 1986-10-03
EP0197876A1 (de) 1986-10-15
EP0197876B1 (de) 1990-07-11
FR2579463B1 (fr) 1988-01-29
IL78269A (en) 1991-08-16
ATE54413T1 (de) 1990-07-15

Similar Documents

Publication Publication Date Title
DE69326292T2 (de) Retinsäuren und Tocopherol enthaltende Zusammensetzungen
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
DE3875837T2 (de) Pharmazeutische und kosmetische mittel, die komplexe von flavanolignanen mit phospholipeden enthalten.
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ATE150292T1 (de) Titansalz enthaltende, schweisshemmende mittel und zusammensetzung
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
ATE183075T1 (de) Retinoid enthaltendes mittel
GB8604528D0 (en) Therapeutic agents
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
DE59610213D1 (de) Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE3672515D1 (de) In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.
ATE204455T1 (de) Topisches antibakterielles mittel
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
ATE81981T1 (de) Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe.
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
DK131586A (da) Transdermalt, antiallergisk, farmaceutisk praeparat
ATE120959T1 (de) Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung.
DE69210727D1 (de) Verwendung von 1,2-Dipalmitoyl-L-Alpha-Phosphatidyl-N,N-Dimethylethanilamine in dermatologischen und kosmetischen Zusammensetzungen
ATE74745T1 (de) Kosmetisches praeparat als spray oder aerosol, verwendbar zur behandlung, pflege und aesthetik der haare.
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
ATE196599T1 (de) Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden
DE68906437T2 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee